There are 2137 resources available
1902P - Association of high-intensity statins with clinical outcome in malignant pleural mesothelioma and advanced non-small cell lung cancer patients treated with PD1 inhibitors
Presenter: Luca Cantini
Session: E-Poster Display
Resources:
Abstract
1903P - Immunotherapy for malignant pleural mesothelioma: A French retrospective real-life study
Presenter: Florian Crépin
Session: E-Poster Display
Resources:
Abstract
1904P - Clinical implications of distinct immunoprofiles in patients with thymic epithelial tumours and autoimmunity
Presenter: Giovannella Palmieri
Session: E-Poster Display
Resources:
Abstract
1905P - BAP1 and miR-31 combination predicts outcome in epithelioid malignant pleural mesothelioma
Presenter: Federica Pecci
Session: E-Poster Display
Resources:
Abstract
1906P - Lung cancer risk in solid organ transplant recipients: A meta-analysis
Presenter: Fan Ge
Session: E-Poster Display
Resources:
Abstract
1907P - Application of anti-PD1 drugs before or during thoracic radiotherapy increases the incidence of radiation pneumonia compared to the application after radiotherapy
Presenter: Nan Zhang
Session: E-Poster Display
Resources:
Abstract
1908P - FGFR1-4 mutations are associated with immunotherapy outcomes in patients with non-small cell lung cancer
Presenter: Ji Chen
Session: E-Poster Display
Resources:
Abstract
1909P - Treatment patterns and outcomes in malignant pleural mesothelioma (MPM) in England: A nationwide CAS registry analysis from the I-O optimise initiative
Presenter: Paul Baas
Session: E-Poster Display
Resources:
Abstract
1910P - Outcomes of systemic therapy after first line therapy in patients (p) with malignant pleural mesothelioma (MPM)
Presenter: Susana Cedres
Session: E-Poster Display
Resources:
Abstract
1911P - Characteristics and real-world outcomes of young lung cancer patients, age ≤45 years, treated in a UK specialist centre
Presenter: Daniel Hughes
Session: E-Poster Display
Resources:
Abstract